Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study aims to boost breastfeeding rates and reduce health gaps

NCT ID NCT05311631

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a program to help more women breastfeed for four to six months, especially those at risk of stopping early. About 5,010 families in Denmark took part. The goal is to improve mother and infant health and reduce social inequalities.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

5,010 people

The number who actually took part.

Started

Apr 2022

Expected to finish

Jun 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

15 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1a. Families discharged \<72 hours post partum (from 26 April 2022 - 17 January 2023) 1b. Families discharged \< 7 days post partum (from 18 January 2023 onwards due to lower than expected recruitment rate) 2\. Families with intention of breastfeeding Exclusion Criteria: * Insufficient skills in Danish or English language to be able to answer questionnaires and understand interventions conveyed in Danish or English * Families with mothers with known substance abuse or addiction * Families expecting more than one child * Families having delivered preterm, prior to 37 weeks of gestation * Families with mothers or child having difficulty breastfeeding due to a known morbidity or disablement

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breastfeeding are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Breast Feeding

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Aabenraa Kommune

    Aabenraa, 6200, Denmark

  • Assens Kommune

    Assens, 5610, Denmark

  • Billund Kommune

    Billund, 7190, Denmark

  • Esbjerg Kommune

    Esbjerg, 6700, Denmark

  • Faaborg-Midtfyn Kommune

    Ringe, 5750, Denmark

  • Fredericia Kommune

    Fredericia, 7000, Denmark

  • Frederikshavn Kommune

    Frederikshavn, 9900, Denmark

  • Haderslev Kommune

    Haderslev, 6100, Denmark

  • Jammerbugt Kommune

    Aabybro, 9440, Denmark

  • Kolding Kommune

    Kolding, 6000, Denmark

  • Mariagerfjord Kommune

    Hobro, 9500, Denmark

  • Middelfart Kommune

    Middelfart, 5500, Denmark

  • Morsø Kommune

    Nykøbing Mors, 7900, Denmark

  • Odense Kommune

    Odense, 5000, Denmark

  • Svendborg Kommune

    Svendborg, 5700, Denmark

  • Sønderborg Kommune

    Sønderborg, 6400, Denmark

  • Thisted Kommune

    Thisted, 7700, Denmark

  • Tønder Kommune

    Tønder, 6270, Denmark

  • Varde Kommune

    Varde, 6800, Denmark

  • Vejen Kommune

    Vejen Municipality, 6600, Denmark

  • Vesthimmerland Kommune

    Aars, 9600, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.